Cardiolipin-incorporated liposomes with surface CRM197 for enhancing neuronal survival against neurotoxicity

International Journal of Pharmaceutics

Volumn 473, Issue 1-2, 2014, Pages 334-344

  Kuo, Yung Chih ^a   Liu, Yu Chuan ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; Cardiolipin; CRM197; Liposome; Neuron growth factor; Amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CARDIOLIPIN; DIPHTHERIA TOXOID CRM197; LIPOSOME; NERVE GROWTH FACTOR RECEPTOR; PROPIDIUM IODIDE; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BACTERIAL PROTEIN; CRM197 (NON-TOXIC VARIANT OF DIPHTHERIA TOXIN); NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT;

ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL SURVIVAL; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; HUMAN; HUMAN BRAIN MICROVASCULAR ENDOTHELIAL CELL; IMMUNOCHEMISTRY; MORPHOLOGY; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; PARTICLE SIZE; PRIORITY JOURNAL; TRANSENDOTHELIAL ELECTRICAL RESISTANCE; ZETA POTENTIAL; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; METABOLISM; TUMOR CELL LINE;

AMYLOID BETA-PEPTIDES; ASTROCYTES; BACTERIAL PROTEINS; BLOOD-BRAIN BARRIER; CARDIOLIPINS; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; LIPOSOMES; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS;

EID: 84905048979     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.07.003     Document Type: Article

References (40)

1. S. Anabousi, M. Laue, C.M. Lehr, U. Bakowsky, and C. Ehrhardt Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy Eur. J. Pharm. Biopharm. 60 2005 295 303
2. E. Bereczki, F. Re, M.E. Masserini, B. Winblad, and J.J. Pei Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells Nanomedicine 7 2011 560 571
3. M. Broker, P. Costantino, L. DeTora, E.D. McIntosh, and R. Rappuoli Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications Biol. Pharm. Bull. 39 2011 195 204
4. C. Bromuro, M. Romano, P. Chiani, F. Berti, M. Tontini, D. Proietti, E. Mori, A. Torosantucci, P. Costantino, R. Rappuoli, and A. Cassone Beta-glucan-CRM197 conjugates as candidates antifungal vaccines Vaccine 28 2010 2615 2623
5. R.S. Chang, J. Kim, H.Y. Lee, S.E. Han, J. Na, K. Kim, I.C. Kwon, Y.B. Kim, and Y.K. Oh Reduced dose limiting toxicity of intraperitoneal mitoxantrone chemotherapy using cardiolipin-based anionic liposomes Nanomedicine 6 2010 769 776
6. C.C. Chao, S. Hu, W.S. Sheng, D. Bu, M.I. Bukrinsky, and P.K. Peterson Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism Glia 16 1996 276 284
7. M. Citron Alzheimer's disease: strategies for disease modification Nat. Rev. Drug Discov. 9 2010 387 398
8. S. Dateoka, Y. Ohnishi, and K. Kakudo Effects of CRM197, a specific inhibitor of HB-EGF, in oral cancer Med. Mol. Morphol. 45 2012 91 97
9. G. Daum Lipids of mitochondria Biochim. Biophys. Acta 822 1985 1 42
10. C. Duyckaerts, B. Delatour, and M.C. Potier Classification and basic pathology of Alzheimer disease Acta Neuropathol. 118 2009 5 36
11. U. Franzen, and J. Ostergaard Physico-chemical characterization of liposomes and drug substance-liposome interactions in pharmaceutics using capillary electrophoresis and electrokinetic chromatography J. Chromatogr. A 1267 2012 32 44
12. P.J. Gaillard, A. Brink, and A.G. de Boer Diphtheria toxin receptor targeted brain drug delivery Int. Congr. Ser. 1277 2005 185 198
13. G. Giannini, R. Rappuoli, and G. Ratti The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197 Nucleic Acids Res. 12 1984 4063 4069
14. M. Gobbi, F. Re, M. Canovi, M. Beeg, M. Gregori, S. Sesana, S. Sonnino, D. Brogioli, C. Musicanti, P. Gasco, M. Salmona, and M.E. Masserini Lipid-based nanoparticles with high binding affinity for amyloid-β1-42 peptide Biomaterials 31 2010 6519 6529
15. A.C. Granholm, D. Albeck, C. Backman, M. Curtis, T. Ebendal, P. Friden, M. Henry, B. Hoffer, J. Kordower, G.M. Rose, S. Soderstrom, and R.T. Bartus A non-invasive system for delivering neural growth factors across the blood-brain barrier: a review Nature Rev. Neurosci. 9 1998 31 55
16. X. Han, J. Liu, M. Liu, C. Xie, C. Zhan, B. Gu, Y. Liu, L. Feng, and W. Lu 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro Int. J. Pharm. 372 2009 125 131
17. S. Hobel, C.C.M. Appeldoorn, P.J. Gaillard, and A. Aigner Targeted CRM197-PEG-PEI/siRNA complexes for therapeutic RNAi in glioblastoma Pharmaceuticals 4 2011 1591 1606
18. F.L. Hoch Cardiolipins and biomembrane function Biochim. Biophys. Acta 1113 1992 71 133
19. S.A. Johnstone, D. Masin, L. Mayer, and M.B. Bally Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages Biochim. Biophys. Acta 1513 2001 25 37
20. Y.C. Kuo, and L.J. Wang Transferrin-grafted catanionic solid lipid nanoparticles for targeting delivery of saquinavir to the brain J. Taiwan Inst. Chem. Eng. 758 2013 1 9
21. Y.C. Kuo, and C.Y. Chung Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells Colloids Surf. B 91 2012 242 249
22. Y.C. Kuo, and C.H. Lu Effect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood-brain barrier Colloids Surf. B 86 2011 225 231
23. O. Lyass, B. Uziely, R. Ben-Yosef, D. Tzemach, N.I. Heshing, M. Lotem, G. Brufman, and A. Gabizon Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma Cancer 89 2000 1037 1047
24. E. Markoutsa, G. Pampalakis, A. Niarakis, I.A. Romero, B. Weksler, P.O. Couraud, and S.G. Antimisiaris Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line Eur. J. Pharm. Biopharm. 77 2011 265 274
25. P. Moongkarndi, C. Srisawat, P. Saetun, J. Jantaravinid, C. Peerapittayamongkol, R. Soi-ampornkul, S. Junnu, S. Sinchaikul, S.T. Chen, P. Charoensilp, V. Thongboonkerd, and N. Neungton Protective effect of mangosteen extract against β-amyloid-induced cytotoxicity, oxidative stress and altered proteome in SK-N-SH cells J. Proteome Res. 9 2010 2076 2086
26. A. Orlando, F. Re, S. Sesana, I. Rivolta, A. Panariti, D. Brambilla, J. Nicolas, P. Couvreur, K. Andrieux, M. Masserini, and E. Cazzaniga Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages Int. J. Nanomedicine 8 2013 1335 1347
27. N.B. Ray, L. Durairaj, B.B. Chen, J.M. Bryan, J.R. Alan, D. Michael, K.W. Alisa, P.O. Christopher, C.H. Florita, A.E. Christopher, M.M. Diann, A. Marianna, C.H.R. Emily, A.C. Tiffany, L.B. Phillip, G. Lokesh, N.M. Satya, C.S. Jessica, Y.T. Yulia, E.K. Valerian, M.L. Geoffrey, and K.M. Rama Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia Nat. Med. 16 2010 1120 1127
28. G.J. Schenk, P.C.J. Haasnoot, M. Centlivre, N. Legrand, J. Rip, A.G. de Boer, and B. Berkhout Efficient CRM197-mediated drug targeting to monocytes J. Control. Release 158 2012 139 147
29. A. Shibata, K. Ikawa, T. Shimooka, and H. Terada Significant stabilization of the phosphatidylcholine bilayer structure by incorporation of small amounts of cardiolipin Biochim. Biophys. Acta 1192 1994 71 78
30. T. Shigeno, T. Mima, K. Takakura, D.I. Graham, G. Kato, Y. Hashimoto, and S. Furukawa Amelioration of delayed neuronal death in the hippocampus by nerve growth factor J. Neurosci. 11 1991 2914 2919
31. M.V. Sofroniew, C.L. Howe, and W.C. Mobley Nerve growth factor signaling, neuroprotection, and neural repair Ann. Rev. Neurosci. 24 2001 1217 1281
32. M. Taylor, S. Moore, Mourta, S. s, A. Niarakis, F. Re, C. Zona, B.L. Ferla, F. Nicotra, M. Masserini, S.G. Antimisiaris, M. Gregor, and D. Allsop Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide Nanomed.: Nanotechnol. Biol. Med. 7 2011 541 550
33. W. Thies, and L. Bleiler Alzheimer's disease facts and figures Alzheimer's Dementia 9 2013 208 245
34. S.R.K. Vaka, S.M. Sammeta, L.B. Day, and S.N. Murthy Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake J. Pharm. Sci. 98 2009 3640 3646
35. I. van Rooy, E. Mastrobattista, G. Storm, W.E. Hennink, and R.M. Schiffelers Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain J. Control. Release 150 2011 30 36
36. P. Wang, Y. Xue, X. Shang, and Y. Liu Diphtheria toxin mutant CRM197-mediated transcytosis across blood-brain barrier in vitro Cell. Mol. Neurobiol. 30 2010 717 725
37. S.K. Wiedmer, J. Hautala, J.M. Holopainen, P.K.J. Kinnunen, and M.L. Riekkola Study on liposomes by capillary electrophoresis Electrophoresis 22 2001 1305 1313
38. Y. Xie, L. Ye, X. Zhang, W. Cui, J. Lou, T. Nagai, and X. Hou Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies J. Control. Release 105 2005 106 119
39. H. Yagi, F. Yotsumoto, K. Sonoda, M. Kuroki, E. Mekada, and S. Miyamoto Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer Int. J. Cancer 124 2009 1429 1439
40. H. Zhang, Y. Lu, D. Mekoo, Y. Zhang, J. Fang, R. Cao, and J. Liu Enhanced inhibition of murine prostatic carcinoma growth by immunization with or administration of viable human umbilical vein endothelial cells and CRM197 Braz. J. Med. Biol. Res. 44 2011 140 148